trial · primary record
JNJ-88549968
Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2028-06-14 |
| Primary endpoint | Part 1, Part 1b (US Only): Number of Participants With Dose Limiting Toxicity (DLT) |
| Registry ID | NCT06150157 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:08.440Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06150157
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.